BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33334812)

  • 1. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
    Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å
    Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.
    Michels KA; Pfeiffer RM; Brinton LA; Trabert B
    JAMA Oncol; 2018 Apr; 4(4):516-521. PubMed ID: 29346467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
    Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
    Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
    Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
    Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
    PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
    Gwinn ML
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
    dos Santos Silva I; Swerdlow AJ
    Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
    Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
    PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pill and cancer: a review of the literature. A case of swings and roundabouts?
    Knowlden HA
    J Adv Nurs; 1990 Sep; 15(9):1016-20. PubMed ID: 2229699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The risk of breast cervical, endometrial and ovarian cancer in oral contraceptive users].
    Veljković M; Veljković S
    Med Pregl; 2010; 63(9-10):657-61. PubMed ID: 21446095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet and risk of breast, endometrial and ovarian cancer: UK Women's Cohort Study.
    Dunneram Y; Greenwood DC; Cade JE
    Br J Nutr; 2019 Sep; 122(5):564-574. PubMed ID: 30526696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial and ovarian cancer and oral contraceptives--findings in a large cohort study.
    Vessey MP; Painter R
    Br J Cancer; 1995 Jun; 71(6):1340-2. PubMed ID: 7779735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
    Jareid M; Thalabard JC; Aarflot M; Bøvelstad HM; Lund E; Braaten T
    Gynecol Oncol; 2018 Apr; 149(1):127-132. PubMed ID: 29482839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and gynecologic cancer: an update for the 1990s.
    Kaunitz AM
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of the data collection process for a multicenter, population-based, case-control design.
    Wingo PA; Ory HW; Layde PM; Lee NC
    Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies.
    Collaborative Group on Epidemiological Studies on Endometrial Cancer
    Lancet Oncol; 2015 Sep; 16(9):1061-1070. PubMed ID: 26254030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women's Health Initiative.
    Adams SV; Quraishi SM; Shafer MM; Passarelli MN; Freney EP; Chlebowski RT; Luo J; Meliker JR; Mu L; Neuhouser ML; Newcomb PA
    Environ Health Perspect; 2014 Jun; 122(6):594-600. PubMed ID: 24633137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.